Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China
Acelyrin创始人林韶莉现身库埃生物制药公司，后者成为最新一家从manbetx3.0 获得许可的企业

Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China.
库埃生物制药公司周四下午宣布重启，引入知名生物科技高管林韶莉（Shao‑Lee Lin），并带来一项在台湾和manbetx3.0 大陆开发的新型过敏资产。